Vivo Capital VIII LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:57 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII LLC | 4,340,212 9.000% |
2,022,432 (+87.26%) |
Filing |
| 2021-02-18 4:53 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII LLC | 2,317,780 9.700% |
2,317,780 (New Position) |
Filing |